![Melio](/sites/default/files/ige/companies/company-logos/Melio.png)
Groundbreaking pathogen identification for near-to-care testing of infections in under 3 hours. Combining digital DNA melting genomic analysis and machine learning, Melio profiles pathogen DNA - to prescribe optimal antimicrobial treatment while reducing the overuse of antibiotics.
Active Companies
https://melio.tech/
IGE MedTech Accelerator
https://melio.tech/
Melio was one of eight female-led startups participating in the mystartupXX program focused on team building, leadership, and more.
Melio has joined the Indie-Bio Accelerator. Watch their latest product video.